Combining the technologies of the two companies will enable the delivery of a revolutionary desktop protein and gene “bioprinter” with breakthrough speed and convenience
Texas A&M biomedical engineering researchers designed a medical device that mimics blood vessels to design and monitor drugs for patients with clotting disorders